This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Conference on Cell & Stem Cell Research" (Stem Cells 2023) August 21-23, 2023 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at stem-cell@magnusconference.com or call + 1 (702) 988 2320.
The use of stem cells to treat or prevent a disease or condition is known as stem-cell therapy. The development of various sources for stem cells, as well as the use of stem-cell therapy for neurological illnesses and conditions including diabetes and heart disease, is currently underway. Following breakthroughs such as scientists' capacity to collect and culture embryonic stem cells, produce stem cells utilising somatic cell nuclear transfer, and apply procedures to create induced pluripotent stem cells, stem-cell therapy has become contentious. Stem cell transplants are treatments that replace blood-forming stem cells in persons whose stem cells have been damaged by high-dose chemotherapy or radiation therapy used to treat certain cancers. Blood-forming stem cells are crucial because they differentiate into many types of blood cells.
Title : The adult stem cells and the cancer stem cells in the context of ovarian cancer
Pushpam Kumar Sinha, Independent Researcher, India
Title : Cell based therapies in articular cartilage repair
Anjali Goyal, NHL Municipal Medical College, India
Title : Comparative study on the effect of adipose-derived stem cells versus alpha-lipoic acid inautologus fat graft survival
Sahar Mohamed Mahdy Omar, Ain Shams University, Egypt
Title : Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis
Asma Alanazi, King Saud Bin Abdulaziz University, Saudi Arabia
Title : Stem cell therapy in radiotherapy from bench to clinical trial evaluating the efficacy of Mesenchymal stromal cell injections for the treatment of chronic pelvic complications induced by radiation therapy
Alain chapel, Institute of Radiological Protection and Nuclear Safety, France
Title : Optimized protocol for generating clinical grade umbilical cord tissue mesenchymal stem cell for cell therapy in various disease
Rekha Kumari, Institute of Liver and Billiary Sciences, India